Sign in

CIK 0001719714 · Non-accelerated filer<br>Smaller reporting company

Mereo BioPharma Group plc

Sign in to watch
Ticker
MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
4403330237300
Business address
ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
  1. SC 13G/A Stake Amended Statement of Ownership
  2. EFFECT Other Notice of Effectiveness
  3. UPLOAD Other SEC-generated Letter
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. F-3 Offering F-3
  6. POS AM Other Post-effective Amendment for Registration Statement
  7. SC 13G Stake Amended Statement of Ownership
  8. 6-K Event Report of Foreign Issuer
  9. 6-K Event Report of Foreign Issuer
  10. 20-F Report Annual and Transition Report of Foreign Private Issuers
  11. SC 13G Stake Amended Statement of Ownership
  12. D Other Notice of Sales of Unregistered Securities
  13. 6-K Event Report of Foreign Issuer
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 6-K Event Report of Foreign Issuer
  16. 6-K Event Report of Foreign Issuer
  17. 6-K Event Report of Foreign Issuer
  18. 6-K Event Report of Foreign Issuer
  19. 6-K Event Report of Foreign Issuer
  20. EFFECT Other Notice of Effectiveness

Page 18 of 23 · 441 filings